Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
Copyright© 2020 Iranian Neuroscience Society..
INTRODUCTION: To assess the opinion of patients with Multiple Sclerosis (MS) on the outcomes of COVID-19 (coronavirus disease 2019) and its effects on MS symptoms if they catch coronavirus. A cross-sectional study was performed.
METHODS: Considering the study objectives, a questionnaire was designed and prepared as a Google Form for MS patients for one week.
RESULTS: A total of 148 MS patients with an average age of 35.73 years completed the questionnaire. The most important concern of the participants was "a high prevalence of COVID-19" following by the "MS symptoms worsening". Many participants (35%) believed that, if they catch COVID-19 they will be cured. However, the treatment will take more time for them in comparison with the general population. About 39.8% of the patients stated that COVID-19 infection does not affect the MS symptom, but others noted that, it can cause relapse (30.8%) or worsen MS symptoms (29.3%).
CONCLUSION: This study revealed that MS patients are more anxious about the effects of COVID-19 on their underlying disease rather than the infection itself.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Basic and clinical neuroscience - 11(2020), 2 vom: 20. März, Seite 201-206 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rezaeimanesh, Nasim [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Concerns |
|---|
| Anmerkungen: |
Date Revised 16.04.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.32598/bcn.11.covid19.2520.1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314290095 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314290095 | ||
| 003 | DE-627 | ||
| 005 | 20231225152418.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.32598/bcn.11.covid19.2520.1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1047.xml |
| 035 | |a (DE-627)NLM314290095 | ||
| 035 | |a (NLM)32855779 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rezaeimanesh, Nasim |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright© 2020 Iranian Neuroscience Society. | ||
| 520 | |a INTRODUCTION: To assess the opinion of patients with Multiple Sclerosis (MS) on the outcomes of COVID-19 (coronavirus disease 2019) and its effects on MS symptoms if they catch coronavirus. A cross-sectional study was performed | ||
| 520 | |a METHODS: Considering the study objectives, a questionnaire was designed and prepared as a Google Form for MS patients for one week | ||
| 520 | |a RESULTS: A total of 148 MS patients with an average age of 35.73 years completed the questionnaire. The most important concern of the participants was "a high prevalence of COVID-19" following by the "MS symptoms worsening". Many participants (35%) believed that, if they catch COVID-19 they will be cured. However, the treatment will take more time for them in comparison with the general population. About 39.8% of the patients stated that COVID-19 infection does not affect the MS symptom, but others noted that, it can cause relapse (30.8%) or worsen MS symptoms (29.3%) | ||
| 520 | |a CONCLUSION: This study revealed that MS patients are more anxious about the effects of COVID-19 on their underlying disease rather than the infection itself | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Concerns | |
| 650 | 4 | |a Coronavirus Disease 2019 (COVID-19) | |
| 650 | 4 | |a Multiple Sclerosis | |
| 650 | 4 | |a Outcome | |
| 700 | 1 | |a Sahraian, Mohammad Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Naser Moghadasi, Abdorreza |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Basic and clinical neuroscience |d 2013 |g 11(2020), 2 vom: 20. März, Seite 201-206 |w (DE-627)NLM242983421 |x 2008-126X |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2020 |g number:2 |g day:20 |g month:03 |g pages:201-206 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.32598/bcn.11.covid19.2520.1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2020 |e 2 |b 20 |c 03 |h 201-206 | ||